The Phase 2/3 trials will be sponsored by Vtesse, a new biotech company that was formed specifically to evaluate the safety and efficacy of cyclodextrin for the treatment of NPC and ultimately obtain FDA labeling if the drug is effective. (sciencedaily.com)
Like carbon - based water filters, the new cyclodextrin polymers owe much of their stickiness to a large surface area. (sciencemag.org)
In the drug trial, researchers have shown that treatment with a type of sugar molecule called cyclodextrin slows progression of the disease. (sciencedaily.com)